Kestra Medical Technologies Ltd (KMTS)

Date: O: H: L: C: Vol:

Finanzdaten der Kestra Medical Technologies Ltd-Aktie (KMTS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-10-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	16.64%28.64	24.55	22.57	19.37	22.57
Cost Of Revenue	11.25%12.96	11.65	11.14	10.52	11.14
Gross Profit	21.51%15.68	12.91	11.42	8.85	11.42
	15.43%55.03	47.67	43.18	37.73	43.18
Selling, General, and Administrative	15.67%49.39	42.70	38.30	33.73	38.30
Research and Development	13.31%5.63	4.97	4.88	4.00	4.88
Operating Income/Loss	13.17%-39.34	-34.77	-31.76	-28.88	-31.76
Income/Loss From Continuing Operations Before Tax	13.22%-38.64	-34.13	-32.75	-25.79	-32.75
Income Tax Expense/Benefit	448.57%0.19	0.04	0.03	0.03	0.03
	13.67%-38.84	-34.17	-32.79	-25.83	-32.79
Attributable To Parent	13.67%-38.84	-34.17	-32.79	-25.83	-32.79
Available To Common Stockholders, Basic	13.67%-38.84	-34.17	-32.79	-25.83	-32.79